Dublin, May 21, 2025 (GLOBE NEWSWIRE) — The “Measles, Mumps, Rubella Vaccine Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” has been added to ResearchAndMarkets.com’s offering.
The Measles, Mumps, Rubella Vaccine Market was valued at USD 1.87 Billion in 2024 and is projected to reach USD 3.04 Billion by 2030, rising at a CAGR of 8.42%. Market growth is being fueled by increasing demand for immunization as a fundamental public health measure.
The inclusion of MMR vaccines in national immunization schedules, bolstered by support from international agencies such as WHO and UNICEF, has led to widespread adoption in both high- and low-income countries. Recurring outbreaks of measles, especially in underserved populations, highlight the need for large-scale vaccination campaigns….